ORSENIX
Orsenix is a clinical-stage biotech company developing a novel oral form of arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) and other cancers. It is committed to transforming cancer treatment with innovative oral therapies that give patients the freedom to live their everyday lives.
ORSENIX
Industry:
Biotechnology Life Science Medical
Address:
Wilmington, Delaware, United States
Country:
United States
Status:
Active
More informations about "Orsenix"
Orsenix (SY-2101) Company Profile 2024: Valuation, Investors ...
Orsenix (SY-2101) General Information Description. Portfolio of Intellectual property, clinical and preclinical data, the regulatory dossier and product inventory related to the development and …See details»
Orsenix Company Profile - Office Locations, Competitors ... - Craft
Orsenix is a clinical-stage biotech company focusing on oral therapies to treat cancer. It develops a capsule form of arsenic trioxide for acute promyelocytic leukemia and other cancers. Type …See details»
Orsenix - Products, Competitors, Financials, Employees, …
In December 2020, Syros acquired from Orsenix, LLC all of its assets related to SY-2101, a novel oral form of ATO. SY-2101 is a targeted clinical-stage drug candidate that has the potential to …See details»
Orsenix LLC: Contact Details and Business Profile
Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) and other cancers. At Orsenix, we are committed …See details»
Syros Pharmaceuticals acquires Orsenix - 2020-12-07 - Crunchbase
Dec 7, 2020 Orsenix Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide. Acquiring Organization: Syros Pharmaceuticals Syros Pharmaceuticals is a …See details»
Orsenix - Company Profile - Tracxn
Nov 27, 2024 Syros Acquires Clinical-Stage Drug Candidate for Acute Promyelocytic Leukemia, Expanding Its Pipeline of Targeted Therapies for Hematologic MalignanciesBusiness Wire • …See details»
Organization | Orsenix LLC
Orsenix LLC Report issue. For profit Phase 1. Founded: Wilmington DE United States (2014 ... Organization Overview. First Clinical Trial. 2016 NCT03048344. First Marketed Drug. None …See details»
Orsenix - Crunchbase
Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide.See details»
Orsenix LLC - Drug pipelines, Patents, Clinical trials - Synapse
Jun 27, 2024 Explore Orsenix LLC with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news.See details»
Orsenix - VentureRadar
Orsenix VentureRadar profile. Find out more about Orsenix, Small Molecule Pharmaceuticals.See details»
Syros Acquires Clinical-Stage Drug Candidate for Acute …
Dec 5, 2020 In addition, Orsenix is eligible to receive a $6 million regulatory milestone related to the development of SY-2101 in APL and commercial milestones of up to $10 million. Orsenix …See details»
Syros Acquires Clinical Candidate for the Treatment of Rare Blood ...
Dec 7, 2020 Syros Pharmaceuticals has acquired Orsenix’ ORH-2014, a targeted clinical-stage drug candidate that has the potential to dramatically reduce the treatment burden of a …See details»
Orsenix - Contacts, Employees, Board Members, Advisors & Alumni
Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide.See details»
Orsenix | Company Profile | Pharmacompass.com
Find Suppliers : API/FDF. Search Our Integrated Database ; Services. Questionnaire For Your Search - Analytical - Analytical Method Development - Biologic Drugs - Capillary …See details»
Orsenix - The Pharmaletter
Orsenix "Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) and other cancers." "Our …See details»
Orsenix, LLC - Georgia Company Directory
Orsenix, LLC was registered on Jan 08 2016 as a domestic limited liability company type with the address 2870 Peachtree Road, PMB 702, Atlanta, GA, 30305, USA. The company id for this …See details»
Top Orsenix Competitors and Alternatives | Craft.co
Orsenix's main competitors include CureVac, PLIVA, Biocon and Shanghai Junshi Biosciences. Compare Orsenix to its competitors by revenue, employee growth and other metrics at Craft.See details»
Chemical Safety and Health - World Health Organization (WHO)
Apr 1, 2016 Arsenic is a metalloid element that forms a number of poisonous compounds. It is widely distributed throughout the Earth’s crust, and can be released into the atmosphere and …See details»
Orsenix LLC: Drug pipelines, Patents, Clinical trials - Synapse
Clinical Trials associated with Orsenix LLC. NCT03048344 / Completed Phase 1 Clinical / Completed Phase 1 ClinicalSee details»